Financhill
Sell
43

GL Quote, Financials, Valuation and Earnings

Last price:
$130.87
Seasonality move :
3.43%
Day range:
$130.27 - $132.02
52-week range:
$100.62 - $147.83
Dividend yield:
0.8%
P/E ratio:
9.48x
P/S ratio:
1.84x
P/B ratio:
1.83x
Volume:
300.4K
Avg. volume:
554.5K
1-year change:
23.36%
Market cap:
$10.4B
Revenue:
$5.8B
EPS (TTM):
$13.81

Analysts' Opinion

  • Consensus Rating
    Globe Life, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $166.70, Globe Life, Inc. has an estimated upside of 27.43% from its current price of $130.82.
  • Price Target Downside
    According to analysts, the lowest downside price target is $145.00 representing -10.84% downside risk from its current price of $130.82.

Fair Value

  • According to the consensus of 7 analysts, Globe Life, Inc. has 27.43% upside to fair value with a price target of $166.70 per share.

GL vs. S&P 500

  • Over the past 5 trading days, Globe Life, Inc. has underperformed the S&P 500 by -3.12% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Globe Life, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Globe Life, Inc. has grown year-over-year revenues for 40 quarters straight. In the most recent quarter Globe Life, Inc. reported revenues of $1.5B.

Earnings Growth

  • Globe Life, Inc. has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Globe Life, Inc. reported earnings per share of $4.73.
Enterprise value:
13.1B
EV / Invested capital:
1.56x
Price / LTM sales:
1.84x
EV / EBIT:
9.25x
EV / Revenue:
2.21x
PEG ratio (5yr expected):
0.56x
EV / Free cash flow:
10.54x
Price / Operating cash flow:
8.77x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.87%
Net Income Margin (TTM):
19.36%
Return On Equity:
21.72%
Return On Invested Capital:
14.28%
Operating Margin:
34.45%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $5.4B $5.7B $5.9B $1.5B $1.5B
Gross Profit -- -- -- -- --
Operating Income $1.3B $1.5B $1.6B $419.9M $521.2M
EBITDA -- -- -- -- --
Diluted EPS $9.66 $11.82 $13.81 $3.44 $4.73
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $1B $1.1B $1.2B $1.3B $1.5B
Total Assets $29.5B $24.8B $26.2B $29.6B $30.5B
Current Liabilities $2.5B $1.4B $1.5B $1.6B $1.7B
Total Liabilities $20.9B $20.5B $21.5B $24.9B $24.8B
Total Equity $8.6B $4.4B $4.6B $4.6B $5.7B
Total Debt $1.9B $1.8B $1.8B $2.3B $2.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $1.5B $1.5B $1.4B $340.6M $306M
Cash From Investing -$1.1B -$921.1M -$196.4M -$196.3M -$73.8M
Cash From Financing -$384.4M -$486.6M -$1B -$95.1M -$171.8M
Free Cash Flow $1.4B $1.4B $1.2B $311.3M $208.7M
GL
Sector
Market Cap
$10.4B
$555.2M
Price % of 52-Week High
88.49%
90.06%
Dividend Yield
0.8%
1.64%
Shareholder Yield
5%
3.16%
1-Year Price Total Return
23.36%
1.45%
Beta (5-Year)
0.481
0.481
Dividend yield:
0.8%
Annualized payout:
$0.95
Payout ratio:
5.71%
Growth streak:
9 years

Technicals

8-day SMA
Sell
Level $132.95
200-day SMA
Buy
Level $129.50
Bollinger Bands (100)
Sell
Level 130.9 - 141.84
Chaikin Money Flow
Buy
Level 346.4M
20-day SMA
Sell
Level $132.42
Relative Strength Index (RSI14)
Sell
Level 41.43
ADX Line
Sell
Level 17.88
Williams %R
Neutral
Level -77.7624
50-day SMA
Sell
Level $134.81
MACD (12, 26)
Sell
Level -0.72
25-day Aroon Oscillator
Buy
Level 68
On Balance Volume
Neutral
Level 318M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.9569)
Sell
CA Score (Annual)
Level (-1.6856)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.0779)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Globe Life, Inc. is an insurance holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Health Insurance, and Investments Insurance. The Life Insurance segment offers products marketed by Globe Life include traditional whole life and term life insurance. The Health Insurance segment is involved in the renewable and includes Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products. The Investments Insurance segment refers to the management of capital resources, including investments, and the management of liquidity. The company was founded on November 19, 1979, and is headquartered in McKinney, TX.

Stock Forecast FAQ

In the current month, GL has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The GL average analyst price target in the past 3 months is $166.70.

  • Where Will Globe Life, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Globe Life, Inc. share price will rise to $166.70 per share over the next 12 months.

  • What Do Analysts Say About Globe Life, Inc.?

    Analysts are divided on their view about Globe Life, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Globe Life, Inc. is a Sell and believe this share price will drop from its current level to $145.00.

  • What Is Globe Life, Inc.'s Price Target?

    The price target for Globe Life, Inc. over the next 1-year time period is forecast to be $166.70 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is GL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Globe Life, Inc. is a Buy. 5 of 7 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of GL?

    You can purchase shares of Globe Life, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Globe Life, Inc. shares.

  • What Is The Globe Life, Inc. Share Price Today?

    Globe Life, Inc. was last trading at $130.87 per share. This represents the most recent stock quote for Globe Life, Inc.. Yesterday, Globe Life, Inc. closed at $130.82 per share.

  • How To Buy Globe Life, Inc. Stock Online?

    In order to purchase Globe Life, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 117.4% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is up 1.62% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 1.03% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock